Walleye Capital LLC cut its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG – Free Report) by 7.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 155,417 shares of the company’s stock after selling 11,695 shares during the quarter. Walleye Capital LLC’s holdings in BrightSpring Health Services were worth $2,647,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of BTSG. FMR LLC boosted its position in BrightSpring Health Services by 21.6% during the 4th quarter. FMR LLC now owns 22,102,490 shares of the company’s stock valued at $376,405,000 after acquiring an additional 3,933,303 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of BrightSpring Health Services by 5.3% during the fourth quarter. Vanguard Group Inc. now owns 5,325,093 shares of the company’s stock valued at $90,686,000 after purchasing an additional 268,132 shares in the last quarter. Invesco Ltd. grew its stake in BrightSpring Health Services by 1.0% in the fourth quarter. Invesco Ltd. now owns 4,378,562 shares of the company’s stock worth $74,567,000 after purchasing an additional 41,991 shares during the period. Norges Bank bought a new position in BrightSpring Health Services in the fourth quarter worth $26,065,000. Finally, Geode Capital Management LLC boosted its holdings in shares of BrightSpring Health Services by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 1,311,204 shares of the company’s stock valued at $22,335,000 after buying an additional 6,990 shares in the last quarter.
Analysts Set New Price Targets
Separately, UBS Group lifted their price target on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. One analyst has rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, BrightSpring Health Services currently has an average rating of “Moderate Buy” and an average target price of $21.67.
BrightSpring Health Services Trading Down 1.2 %
NASDAQ:BTSG opened at $16.60 on Friday. BrightSpring Health Services, Inc. has a 52 week low of $10.15 and a 52 week high of $24.82. The stock has a market cap of $2.90 billion, a price-to-earnings ratio of -63.85 and a beta of 2.02. The company’s 50 day moving average price is $18.47 and its 200-day moving average price is $18.32. The company has a quick ratio of 0.97, a current ratio of 1.35 and a debt-to-equity ratio of 1.63.
BrightSpring Health Services Company Profile
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Recommended Stories
- Five stocks we like better than BrightSpring Health Services
- Stock Market Sectors: What Are They and How Many Are There?
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- There Are Different Types of Stock To Invest In
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- Differences Between Momentum Investing and Long Term Investing
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Want to see what other hedge funds are holding BTSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BrightSpring Health Services, Inc. (NASDAQ:BTSG – Free Report).
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.